These conjugates exhibit enhanced selective cytotoxicity towards BC cells (MCF-7 and MDA-MB-231), compared to non-cancerous breast cells (184B5) due to higher GLUT5-mediated uptake in cancer cells (Nahrjou et al. 2021). The gene discussed is SLC2A5; the disease is breast cancer.